- Home
- FLWS vs AARD Comparison
FLWS vs AARD Comparison
Compare FLWS & AARD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLWS | AARD |
|---|---|---|
| Founded | 1976 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.7M | 231.9M |
| IPO Year | 1999 | 2025 |
Fundamental Metrics
Financial Performance| Metric | FLWS | AARD |
|---|---|---|
| Price | $3.44 | $9.26 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | $7.50 | ★ $30.63 |
| AVG Volume (30 Days) | ★ 753.0K | 147.7K |
| Earning Date | 10-30-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,658,768,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $0.93 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.93 | $4.88 |
| 52 Week High | $9.17 | $19.58 |
Technical Indicators
Market Signals| Indicator | FLWS | AARD |
|---|---|---|
| Relative Strength Index (RSI) | 46.78 | 39.77 |
| Support Level | $3.35 | $9.28 |
| Resistance Level | $3.40 | $10.44 |
| Average True Range (ATR) | 0.18 | 0.81 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 84.30 | 16.36 |
Price Performance
Historical ComparisonAbout FLWS 1-800-FLOWERS.COM Inc.
1-800-Flowers.com Inc is a provider of gifts designed to help customers express, connect, and celebrate. The company's e-commerce business platform features all brands, including 1-800-Flowers.com, 1-800-Baskets.com, Cheryl's Cookies, Harry and David, PersonalizationMall.com, Shari's Berries, FruitBouquets.com, Moose Munch, The Popcorn Factory, Wolferman's Bakery, Stock Yards, and Simply Chocolate. The company's business segments are; Consumer Floral and Gifts, BloomNet, and Gourmet Foods & Gift Baskets. The maximum revenue for the company is generated from its Gourmet Foods & Gift Baskets segment.
About AARD Aardvark Therapeutics Inc.
Aardvark Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. It is focused on on developing selective compounds, targeting Bitter Taste Receptors (TAS2Rs) for hunger-associated conditions. Its product candidate, ARD-101, is an oral gut-restricted small-molecule agonist of certain TAS2Rs expressed in the gut lumen for which have initiated a Phase 3 clinical trial for hyperphagia associated with PWS.